FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.

2.

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

3.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

4.

Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.

5.

Opposition to the Surgical Lymph Node Sampling Rule for Lung Resection.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot